Yes TC, read your post, any B would be awesome. Should be no problem to secure funding and confirm operations for 2020 on track. Valuation could help to support pps, I understand pending S1 but if all good create some confidence in the company. AE37/MRK update would be appreciated, also NGIO shares they may owe you and others should be clarified and Form 10 regarding IP - they mentioned certain patents were expired ?? The plans and acquisitions are costly, do we really have the support/funds we need and able to execute as promised or should they slow down a little and concentrate on a few and get it done before signing new deals. NASDAQ has been a struggle and it continues to be an issue.......the question remains why???
At the end of the "today" its all good because we are still here !!
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links